Epitomics
Burlingame · Founded 2001
About Epitomics
Epitomics, an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research and diagnostic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity, specificity and bioactivity both in vitro and in vivo. Epitomics, Inc. is headquartered in Burlingame, California, and operates wholly owned subsidiaries in Hong Kong and Hangzhou, the People’s Republic of China.
Company Facts
- Founded: 2001
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Series Unknown (Jan 2001)
- Website: epitomics.com
- Phone: 6505836680
Social Profiles
Canonical: https://fsome.com/organization/epitomics-8288722 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.